Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
69 Cards in this Set
- Front
- Back
Common side effect of hypnotic agents
|
Sedation
|
|
Occurs when sedative hypnotics are used chronically or at high doses
|
Tolerance
|
|
The most common type of drug interaction of sedative hypnotics w/ other depressant medications
|
Additive CNS Depression
|
|
Benzodiazepines used to promote sleep
|
Temazapam, trizolam, flurazepam
|
|
Benzodiazepine used for anxiety
|
Alprazolam
|
|
non-benzodiazepine used as an anxiolytic
|
Buspirone
|
|
non-benzodiazepine used for sleep
|
Zolpidem
|
|
Major effect of benzodiazepines on sleep at high doses
|
DECREASES REM
|
|
Neurologic SE of benzodiazepines
|
Anterograde amnesia
|
|
Reason benzos are used cautiously in pregnancy
|
Ability to cross placenta
|
|
Main route of metabolism for benzo's
|
Hepatic
|
|
Benzo that undergoes extrahepatic conjugation (which are useful in older ppl or hepatically impaired)
|
Lorazepam, oxazepam, temazepam
|
|
MOA for benzo's
|
Increase the FREQUENCY of GABA - mediated chloride ion channel opening
|
|
Antidote to benzo overdose (antagonist that reverses the CNS effects)
|
Flumazenil
|
|
Benzo with useful relaxant effects in skeletal muscle spasticityof central origin
|
Diazepam
|
|
Benzo that has efficacy against absence seizures and in anxiety states, such as AGORAPHOBIA
|
Clonazepam
|
|
Benzo's that are the moes effect in the treatment of PANIC disorder
|
Alprazolam & Clonazepam
|
|
Benzo used for anesthesia
|
Midazolam
|
|
DOC for status epilepticus
|
Diazepam
|
|
Longer acting benzo used in the management of withdrawal states if alcohol and other drugs
|
Chlordiazepoxide and Diazepam
|
|
Agents having active metabolites, long half-lives and a high incidence of adverse effects
|
Diazepam, flurazepam, chlordiazepoxide and clorazepate
|
|
Baebiturates may precipitate this hematologic condition
|
Acute intermittent Porphyria
|
|
Baebiturates decrease the effectiveness of many other drugs viz this pharmacokinetics property
|
Liver enzyme INDUCTION
|
|
Baebiturates MOA
|
Increase the DURATION of GABA-mediated chloride ion channels
|
|
Baebiturate used for the induction of anesthesia
|
Thiopental
|
|
Site of action of zaleplon & zolpidem
|
Bezodiazepine receptor BZ1
(although mdo not have a benzodiazepine ring structure) |
|
Good hypnotic activity with less CNS SE than most benzo's
|
Zolpidem, zaleplon
|
|
Agent that is a partial agonist for the 5-HT1A receptor
|
Buspirone
|
|
DOC for generalized anxiety disorder, NOT effective in acute anxiety
|
Buspirone
|
|
Agent that is metabolized to acetaldehyde by alcohol dehydrogenase and microsomal ethanol-oxidizing system (MEOS)
|
Ethanol
|
|
Agent with zero-order kinetics
|
Ethanol
|
|
Rate limiting step of alcohol metabolism
|
Aldehyde dehydrogenase
|
|
System that increases in activity with chronic EtOH exposure and may contribute to tolerance
|
MEOS
|
|
Enzyme that metabolizes acetaldehyde to acetate
|
Aldehyde dehydrogenase
|
|
Agents that inhibit Alchohol dehydrogenase
|
Disulfirm, metronidazole, certain sulfonylureas, and cephalosporins
|
|
Agent used in the tx of ALCOHOLISM, if alcohol is consumed concurrently, adetaldehyde builds up and results in nausea, HA, flushing and hypotension
|
Disulfiram
|
|
The most common neurologic abnormality in chronic alcoholics
|
Peripheral neuropathy (also excessive alcohol use is assoc. with HTN, anemia, and MI)
|
|
Agent that is a teratogen and causes a Fetal syndrome
|
Ethanol
|
|
Agent that is the antidote for methanol overdose
|
Ethanol, fomepizole
|
|
Drug that inhibits alcohol dehydrogenase and is used in ethylene glycol exposure
|
Fomepizole
|
|
MOA of general anesthetics
|
Most are thought to act at GABA-A receptor - chlorida channel
|
|
Inhaled anesthetic with low blood/gas partition coefficient
|
Nitrous oxide
|
|
Inversely related to potency of anesthetics
|
MAC - Minimum alveolar anesthetic concentration
|
|
Inhaled anesthetics metabolized by liver enzymes which has a major role in the toxicity of these agents
|
Halothane and methoxyflurane
|
|
Most inhaled anesthetics SE
|
Decrease arterial BP
|
|
Inhaled anesthetics that are myocardial
|
Enflurane and Halothane
|
|
Inhaled anesthetic that causes periphera vasodilation
|
Isoflurane
|
|
Inhaled anesthetic that may sensitize the myocardium to arrhythogenic effects of catecholamines and has produced Hepatitis
|
Halothane - Hepatitis
|
|
Inhaled anesthetic less liekly to lower BP than other agents and has smallest effect on respiration
|
Nitrous oxide
|
|
Fluoride released by metabolism of this inhaled anesthetic may cause renal insufficiency
|
Methoxyflurane
|
|
Prolonged exposure to this inhaled anesthetic may lead to MEGALOBLASTIC ANEMIA
|
Nitrous oxide
|
|
PUNGENT inhaled anesthetic which leads to high incidence of coughing and vasospasm
|
Desflurane
|
|
DOC for MALIGNANT HYPERTHERMIA that may be caused by used of halogenated adesthetics
|
Dantolene
|
|
IV barbiturate used as a pre-op anesthetic
|
Thiopental
|
|
Benzo used adjunctively in anesthesia
|
Midazolam
|
|
Benzo receptor antagonist, it accelerates recovery from benzo overdose
|
Flumazenil
|
|
This produces "dissociative anesthesia" is a cardiovascular stimulant which may increase intracranial pressure, and hallucinations occur during recovery
|
Ketamine
|
|
Opioid associated with respiratory depression, but is used in high risk patients who may not survive full general anesthetic
|
Fentanyl
|
|
State of analgesia and amnesia produced when fentanyl is used with droperidol with NO
|
Neuroleptanestheia
|
|
Produces both rapid anesthesia and recovery, has antiemetic activity and commonly used for outpatient surgery, may cause marker hypotension
|
Propofol
|
|
Structurally related to acetylcholine, used to produce muscle paralysis in order to facilitate surgery or artificial ventilation. Full doses lead to respiratory paralysis and require ventilation
|
Neuromuscular blocking agents
|
|
These drugs strongly potentiate and prolong the effect of neuromuscular blockade (NMB)
|
Inhaled anesthetics, especially isoflurane, aminoglycosides, and antiarrhythmic
|
|
These prevent the action of ACh at the skeletal m. endplate to produce "surmountable blockade" effect is reversed by cholinesterase inhibitors (ex. neostigmine or pyridostigmine)
|
Nondepolarizing type antagonists
|
|
Agenst with long duration of action and is most likely to cause histamine release
|
Tubocurarine
|
|
Non-depolarizing skeletal muscle antagonist that has short duration
|
Mivacurium
|
|
Skeletal m. agent that can block muscarinic receptors
|
Pancuronium
|
|
Skeletal m. agent that undergoes Hofmann elimination ( breaks down spontaneously )
|
Atracurium
|
|
One depolarizing blocker that causes continuous depolarization and results in muscle relaxation and paralysis, causes muscle pain postoperatively and myoglobinuria may occur
|
Succinylcholine
|
|
During Phase I these agents worsen muscle paralysis by succinylcholine, but during phase II they reverse the blockade produced by succ.
|
Cholinesterase Inhibitors
|